Pharmacokinetics of [18F]FETNIM: A potential hypoxia marker for PET

Journal of Nuclear Medicine

Volumn 42, Issue 9, 2001, Pages 1397-1404

  Gronroos T ^a   Eskola, O ^a   Lehtio K ^a   Minn, H ^a   Marjamaki P ^a   Bergman, J ^a   Haaparanta, M ^a   Forsback, S ^a   Solin, O ^a  

^a TURKU PET CENTRE   (Finland)

Author keywords

18F fluoroerythronitroimidazole; Biodistribution; Hypoxia; Metabolism; PET

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; FLUOROERYTHRONITROIMIDAZOLE F 18; PLASMA PROTEIN; TRACER; UNCLASSIFIED DRUG; FLUORINE; FLUOROERYTHRONITROIMIDAZOLE; NITROIMIDAZOLE DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOXIA; METABOLISM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY; ANIMAL; ANOXIA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOG; EXPERIMENTAL NEOPLASM; HEAD AND NECK TUMOR; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; ANOXIA; DOGS; FEMALE; FLUORINE RADIOISOTOPES; HEAD AND NECK NEOPLASMS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034843378     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
2. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
3. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
4. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
5. Measuring tumor hypoxia
6. Hypoxic sensitizers: Implications for radiation therapy
7. Misonidazole labeling as a marker of cellular hypoxia
8. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells
9. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
10. 18F]fluoromisonidazole: A pretherapy study of 37 patients
11. 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissue
12. Development of F-18-1abeled fluoroeryth-ronitroimidazole as a PET agent for imaging tumor hypoxia
13. 18F]fluoroalkyl-2-nitroimidazoles for imaging hypoxia
14. 18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia
15. 18F]EF1
16. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
17. Radioiodinated 1-(5-iodo-5-deoxy-β-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): A novel marker of tissue hypoxia
18. Imaging tumor hypoxia and tumor perfusion
19. 123I-IAZA in healthy volunteers
20. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia
21. 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia
22. 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors
23. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia
24. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model
25. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data
26. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
27. Comparison of the distribution of fluotine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue
28. Nitroimidazole drugs: Action and resistance mechanisms. 1. Mechanisms of action
29. Binding of metronidazole and its derivatives to plasma proteins: An assessment of drug binding phenomenon
30. Tinidazole and metronidazole pharmocokinetics in man and mouse
31. Comparative pharmacokinetic studies of omidazole and metronidazole in man
32. Pharmacokinetics of hypoxic cell radiosensitizers